GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
Nexwise Intelligence China
301248
Astro-century Education & Technology
300654
CN Stock MarketDetailed Quotes
002550 Changzhou Qianhong Biopharma
- 5.76
- -0.11-1.87%
Trading Jan 24 13:44 CST
7.37BMarket Cap25.15P/E (TTM)
6.00High5.73Low181.41KlotVolume5.99Open5.87Pre Close105.53MTurnover1.99%Turnover Ratio40.56P/E (Static)1.28BShares7.1852wk High2.98P/B5.24BFloat Cap4.0852wk Low6.46Limit Up910.23MShs Float15.99Historical High5.28Limit Down4.60%Amplitude0.85Historical Low0.12Dividend TTM5.82Avg Price101.94KlotAsk2.08%Div YieldTTM100Lot Size77.66KlotBid
Changzhou Qianhong Biopharma News
Qianhong Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Qianhong Pharmaceutical: Legal Opinion of the Third Extraordinary General Meeting of Shareholders in 2024
Qianhong Pharmaceutical: Prompt Announcement on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Corrected Notice Concerning the Notice of Convening the Third Extraordinary General Meeting of Shareholders in 2024
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Notice on the Notice of Convening the Third Extraordinary General Meeting of Shareholders in 2024
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Prompt Notice on Disclosure of Plans to Issue Convertible Corporate Bonds to Unspecified Targets
Qianhong Pharmaceuticals: Qianhong Pharmaceuticals: Convertible Corporate Bondholders\' Meeting Rules
Qianhong Pharmaceutical: 2024-049 Qianhong Pharmaceutical: Announcement on Issuance of Convertible Corporate Bonds to Unspecified Targets, Diluted Immediate Returns and Compensation Measures and Related Entity Commitments
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Demonstration Analysis Report on Issuance of Convertible Corporate Bonds Issuance Plan to Unspecified Targets
Qianhong Pharmaceutical: 2024-047 Qianhong Pharmaceutical: Plan to issue convertible corporate bonds to unspecified targets
Qianhong Pharmaceutical: Shareholders\' Meeting Proceedings Compilation
Qianhong Pharmaceuticals: Qianhong Pharmaceuticals: Shareholder Return Plan for the Next Three Years (2024-2026)
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Feasibility Analysis Report on the Use of Funds Raised by Issuing Convertible Corporate Bonds to Unspecified Targets
Qianhong Pharmaceuticals: Qianhong Pharmaceuticals: Legal Opinion of the 2024 Second Extraordinary General Meeting of Shareholders
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement on the completion and termination of the first phase of the company\'s employee shareholding plan Qianhong Pharmaceutical No. 1
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement on the signing of the “Investment Agreement on the Reorganization of Changzhou Fangyuan Pharmaceutical Co., Ltd.”
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Notice on the Notice of Convening the 2024 Second Extraordinary General Meeting of Shareholders
Qianhong Pharmaceutical: 2024-034 Qianhong Pharmaceutical: Announcement on the signing of a settlement agreement between the company and Jianyuan Trust Co., Ltd. and the progress of litigation
Changzhou Qianhong Biopharma: Interim financial statements.